Schedule 13G ownership disclosure
DiaMedica Therapeutics Inc
Security class unavailable · CUSIP: 25253X207
Event date: 2020-02-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 800,000
- Percent of class
- 5.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-20-000089
- Form type
- SC 13G
- Filer
- DiaMedica Therapeutics Inc.
- CIK
- CIK 1401040
- Filed
- Feb 12, 2020
- Reporting period
- Feb 11, 2020
- Description
- Schedule 13G beneficial ownership